UNCONVENTIONAL INNOVATIONS PROGRAM

Release Date:  September 4, 1998

P.T.

National Cancer Institute

The National Cancer Institute (NCI) announces the creation of the
Unconventional Innovations Program (UIP) to fund the development of high
impact, long-range technologies to support cancer research.  Initial plans
target $48 million in the UIP over the next 5 years for technology platforms
to enable integration of:

o  non-invasive sensing of molecular alterations in vivo
o  transmission of molecular information to an external monitor
o  controlled intervention specific for the molecular profile
o  monitoring of intervention

The NCI is soliciting input from researchers about technologies that could
fundamentally change the approach to the detection, diagnosis, and treatment
of cancer.  Submitted information will help define the general scope of a
Broad Agency Announcement to fund research that will be issued in late 1998 or
early 1999.

Ideas are requested in the form of white papers, which address:

o  nature of the technological opportunity
o  current capability of the technology
o  technological barriers to meeting the defined goal
o  contribution to the opportunity for the non-intrusive sensing, signaling,
and intervention for cancer based on tumor specific molecular profiles
o  potential impact on the detection, diagnosis, and treatment of cancer

INQUIRIES

For further information and guidance see:  http://amb.nci.nih.gov/ 

For programmatic issues contact:

Carol Dahl, Ph.D.
Office of Technology and Industrial Relations
National Cancer Institute
31 Center Drive, Room 11A03, MSC 2590
Bethesda, MD 20892-2590
Telephone:   (301) 496-1550
FAX:  (301) 496-7807
Email:  [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)